Collateral damage: microbiota-derived metabolites and immune function in the antibiotic era

Cell Host Microbe. 2014 Aug 13;16(2):156-163. doi: 10.1016/j.chom.2014.07.009.

Abstract

Our long-standing evolutionary association with gut-associated microbial communities has given rise to an intimate relationship, which affects many aspects of human health. Recent studies on the mechanisms that link these microbial communities to immune education, nutrition, and protection against pathogens point to microbiota-derived metabolites as key players during these microbe-host interactions. A disruption of gut-associated microbial communities by antibiotic treatment can result in a depletion of microbiota-derived metabolites, thereby enhancing pathogen susceptibility, impairing immune homeostasis, and contributing to the rise of certain chronic inflammatory diseases. Here, we highlight some of the recently elucidated mechanisms that showcase the impacts of microbiota-derived metabolites on human health.

Publication types

  • Research Support, N.I.H., Extramural
  • Review

MeSH terms

  • Animals
  • Anti-Bacterial Agents / adverse effects
  • Anti-Bacterial Agents / pharmacology*
  • Butyric Acid / metabolism
  • Homeostasis
  • Humans
  • Intestine, Large / immunology
  • Intestine, Large / microbiology*
  • Microbiota / drug effects
  • Microbiota / physiology*

Substances

  • Anti-Bacterial Agents
  • Butyric Acid